Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ATREUS: Trabectedin in Pretreated Malignant Pleural Mesothelioma
NCT02194231Phase 2Completed
- Sponsor
- Mario Negri Institute for Pharmacological Research
- Start
- Jul 2013
- Primary completion
- Dec 2019
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trabectedin in malignant pleural mesothelioma (MPM), sponsored by Mario Negri Institute for Pharmacological Research. Started Jul 2013; status: completed.
02
Drugs
trabectedin
03
Conditions
malignant pleural mesothelioma (MPM)
Beyond the preview
Go deeper on NCT02194231.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02194231.